India's Dr Lal Path Labs gains on considering issue of bonus shares
** Shares of Dr Lal Path Labs DLPA.NS climb 2.3% to 3,118.2 rupees ** Diagnostics firm to consider issuing bonus shares at a board meeting scheduled on October 31; it will also consider declaration of an interim dividend ** Stock on track to snap three straight sessions of losses ** DLPA rated "Buy" on avg, same as rival Metropolis Healthcare METP.NS - data compiled by LSEG ** YTD, DLPA up ~4% vs ~7% decline in METP (Reporting by Manvi Pant) ((Manvi.Pant@thomsonreuters.com; +918447554364;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise